Chlorides-buliding-blocks

On April 1, 2021, Xiong, Shili; Wang, Nan; Liu, Chao; Shen, Huaxing; Qu, Zengqiang; Zhu, Lijun; Bai, Xiaosong; Hu, Hong-gang; Cong, Wei; Zhao, Liang published an article.SDS of cas: 98946-18-0 The title of the article was Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics. And the article contained the following:

Brevinin-1BYa is an amphibian skin-derived peptide that exhibits promising anti-microbial activity against gram-pos. and -neg. bacteria. However, the anti-tumor activity of Brevinin-1BYa remains unclear, and, more importantly, its therapeutic application is limited owing to its poor protease and reduction stability. In this study, a series of novel Brevinin-1BYa derivatives, including O-linked N-acetyl-glucosamine glyclopeptides and disulfide bond mimetics, were designed and synthesized. Addnl., their anti-tumor activity against human prostate cancer cell line C4-2B, human NSCLC cell line A549 (adenocarcinoma), and human hepatoma cells line HuH-7 was investigated. Among these, the thioether bridge substituted peptidomimetic Brevinin-1BYa-3 displayed improved reduction stability, more stable secondary structure, greater protease stability, and increased anti-tumor activity compared with the original peptide, rendering it a promising leading compound for drug development, particularly for applications against malignant tumors. The experimental process involved the reaction of tert-Butyl trichloroacetimidate(cas: 98946-18-0).SDS of cas: 98946-18-0

The Article related to cyclic peptide synthesis glycopeptide antitumor structure activity drug design, homoserine bromination solid phase synthesis peptide coupling oxidative cyclization, peptidomimetic click chem azide alkyne cycloaddition copper catalyst lactamization, secondary structure enzymic stability peptide folding hemolysis, anti-tumor activity, brevinin-1bya and other aspects.SDS of cas: 98946-18-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On September 29, 1993, Axelsson, Oskar; Peters, Dan; Nielsen, Elsebet Ostergaard; Christophersen, Palle published a patent.Electric Literature of 38939-88-7 The title of the patent was Imidazole compounds, their preparation and use. And the patent contained the following:

The title compounds, particularly the benzimidazole derivatives and 3H-imidazo[4,5-b]pyridine derivatives, I (X, Y = carbon, nitrogen; R12, R13 = alkyl; R4-R7 = H, halo, amino, cyano, etc.) and their uses for the treatment of diseases responsive to blocking of calcium channels of the central nervous system are claimed. Such diseases include degenerative changes associated with stroke, ischemia, migraine, psychosis, Parkinson’s disease, depression, epilepsy, or convulsive disorders. For example, 1-(4-iodophenyl)-4-fluorobenzimidazole (II) had an in vitro activity as L-type calcium channel blocker. Other I were tested for activity as N-type and P-type calcium channel blockers. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Electric Literature of 38939-88-7

The Article related to ischemia benzimidazole imidaopyridine phenyl, migraine benzimidazole imidaopyridine phenyl, antipsychotic benzimidazole imidaopyridine phenyl, antidepressant benzimidazole imidaopyridine phenyl, antiepileptic benzimidazole imidaopyridine phenyl, anticonvulsant benzimidazole imidaopyridine phenyl, calcium channel blocker benzimidazole imidaopyridine and other aspects.Electric Literature of 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On May 4, 1999, Shea, Kenneth J.; Staiger, Chad L.; Lee, Sun Y. published an article.Application In Synthesis of trimethyloxosulphonium chloride The title of the article was Synthesis of Polymethylene Block Copolymers by the Polyhomologation of Organoboranes.. And the article contained the following:

AB and ABA block copolymers of poly(ethylene glycol-b-methylene) and poly(dimethylsiloxane-b-methylene) were prepared by hydroboration polyhomologation protocol. Control over the chain length of the polymethylene block was achieved by adjusting the initial molar ratio of ylide to organoborane. ABA block copolymers of polymethylene-polydimethylsiloxane-polymethylene were synthesized by a similar approach using thexyl borane as the difunctional hydroboration agent. The experimental process involved the reaction of trimethyloxosulphonium chloride(cas: 5034-06-0).Application In Synthesis of trimethyloxosulphonium chloride

The Article related to polymethylene block copolymer polyethylene glycol synthesis hydroboration polyhomologation, polysiloxane polymethylene block copolymer synthesis thexyl borane hydroboration agent, dimethylsulfoxonium methylide block polymer oxirane dimethylsiloxane synthesis hydroboration polyhomologation, ylide polymerization polymethylene block copolymer synthesis and other aspects.Application In Synthesis of trimethyloxosulphonium chloride

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On August 31, 1999, Shea, Kenneth J.; Staiger, Chad L.; Lee, Sun Y. published an article.Synthetic Route of 5034-06-0 The title of the article was Synthesis of Polymethylene Block Copolymers by the Polyhomologation of Organoboranes.. And the article contained the following:

AB and ABA block copolymers of poly(ethylene glycol-b-methylene) and poly(dimethylsiloxane-b-methylene) were prepared by hydroboration polyhomologation protocol. Control over the chain length of the polymethylene block was achieved by adjusting the initial molar ratio of ylide to organoborane. ABA block copolymers of polymethylene-polydimethylsiloxane-polymethylene were synthesized by a similar approach using thexyl borane as the difunctional hydroboration agent. The experimental process involved the reaction of trimethyloxosulphonium chloride(cas: 5034-06-0).Synthetic Route of 5034-06-0

The Article related to polymethylene block copolymer polyethylene glycol synthesis hydroboration polyhomologation, polysiloxane polymethylene block copolymer synthesis thexyl borane hydroboration agent, dimethylsulfoxonium methylide block polymer oxirane dimethylsiloxane synthesis hydroboration polyhomologation, ylide polymerization polymethylene block copolymer synthesis and other aspects.Synthetic Route of 5034-06-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On September 2, 2011, Curti, Claudio; Battistini, Lucia; Sartori, Andrea; Lodola, Alessio; Mor, Marco; Rassu, Gloria; Pelosi, Giorgio; Zanardi, Franca; Casiraghi, Giovanni published an article.Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate The title of the article was Catalytic, Asymmetric Hypervinylogous Mukaiyama Aldol Reactions of Extended Furan-Based Silyl Enolates. And the article contained the following:

Vinyl, butadienyl, and hexatrienyl siloxyfurans such as I (TBS = tert-butyldimethylsilyl) are prepared; in the presence of silicon tetrachloride and nonracemic bis(dinaphthodiazaphosphepine) II, I undergo regioselective, stereoselective, and enantioselective vinylogous Mukaiyama aldol addition reactions with aryl aldehydes to yield nonracemic hydroxyalkylidenefuranones such as III in 42-92% yields, in 55:45->95:5 olefin stereoselectivities, and in 89:11->99:1 er. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

The Article related to vinyl butadienyl hexatrienyl siloxyfuran preparation regioselective stereoselective aldol addition, hydroxyalkylidenefuranone regioselective stereoselective preparation, silicon chloride dinaphthodiazaphosphepine catalyst regioselective enantioselective hypervinylogous aldol addition, vinylogous mukaiyama aldol addition vinyl siloxyfuran aryl aldehyde and other aspects.Reference of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On December 31, 1998, Kawanishi, Hiroyuki; Morimoto, Hiroshi; Nakano, Takao; Watanabe, Tatsuya; Oda, Kuniyuki; Tsujihara, Kenji published an article.Category: chlorides-buliding-blocks The title of the article was Stereoselective synthesis of antifungal sulfoximines, novel triazoles II. And the article contained the following:

Novel triazole derivatives I (R = H, MeCO, MeNHCO, Me, MeO2CCH2) with an N-substituted sulfoximine moiety were synthesized and evaluated for antifungal activity. These compounds showed significantly weaker activity than I (R = H); the N-H moiety of the sulfoximine was extremely important for the activity. A practical and effective stereoselective synthesis of (-)-I (R = H), considered to be the most promising antifungal compound, has been developed. (-)-I (R = H) is prepared in seven steps, including two resolution steps, from the methylthiodifluoropropiophenone II, by epoxidation with Me3SO+ Cl-, diastereoselective sulfimine formation with chloramine T, addition of 1,2,4-triazole to the epoxide, oxidation of the sulfimine, acid hydrolysis of toluenesulfonyl group of the sulfoximine, and resolution with the novel resolving agent 1-(2,3,4-trichlorophenyl)ethanesulfonic acid [(+)-TCPES] III. The experimental process involved the reaction of trimethyloxosulphonium chloride(cas: 5034-06-0).Category: chlorides-buliding-blocks

The Article related to triazole sulfoximine derivative preparation, sulfoximine triazole prospective antifungal agent nonracemic stereoselective practical preparation, stereoselective synthesis antifungal sulfoximine novel triazole, antifungal activity triazole sulfoximine nitrogen substitution, chlorophenylethanesulfonic acid tcpes novel resolving agent sulfoximine triazole and other aspects.Category: chlorides-buliding-blocks

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On April 16, 2021, Xu, Changming; Qi, Yinsheng; Yang, Xinshuang; Li, Xiangfan; Li, Zhenpeng; Bai, Lei published an article.HPLC of Formula: 14602-86-9 The title of the article was Development of C2-Symmetric Chiral Spirocyclic Phase-Transfer Catalysts: Synthesis and Application to Asymmetric Alkylation of Glycinate Schiff Base. And the article contained the following:

A class of C2-sym. chiral spirocyclic phase-transfer catalysts based on the tetramethyl-1,1′-spirobiindane scaffold such as I·Br- was synthesized from com. available bisphenol A in 12 steps in 22-25% total yields; the scaffold features a more rigid and stable backbone and smaller dihedral angles and can be easily modified. These catalysts show high catalytic performance in the asym. alkylation of tert-Bu glycinate Schiff base Ph2C:NCH2CO2t-Bu at only 2 mol % catalyst loading, giving nonracemic protected α-amino acid esters such as (R)-Ph2C:NCH(CH2Ph)CO2t-Bu in up to 92% yield and 98% ee. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).HPLC of Formula: 14602-86-9

The Article related to spirobiindanoazocinium nonracemic preparation catalyst enantioselective phase transfer alkylation, diphenylmethyleneamino ester enantioselective preparation, nonracemic spirobiindanoazocinium bromide enantioselective phase transfer alkylation catalyst, alkyl bromide enantioselective alkylation diphenylmethyleneamino ester spirobiindanoazocinium catalyst and other aspects.HPLC of Formula: 14602-86-9

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On February 1, 2021, Kadaiahgari, Chandra Sekhar; Saha, Moumita; Ravuri, Srinath; Nandigama, Sandeep; Saha, Krishna Das; Banerji, Biswadip published an article.Formula: C7H6ClNO2 The title of the article was Sulphonamide-Containing Oxazoline Hybrids as New Class of Neuroprotective Agents and Lead Molecule as Autophagy Inducer. And the article contained the following:

In the present study, a series of sulfonamide containing oxazoline hybrids I [R1 = 2-NH2, 3-NH2, 4-NH2; R2 = H, Cl, MeO; R3 = H, MeO; R2R3 = HC=CHCH=CH] were synthesized and their neuroprotective efficacy in neuronal cell lines was explored. All the compounds I showed moderate to good neuroprotection against adrenal medulla cell lines (PC 12). Compound I [R1 = 4-NH2; R2R3 = HC=CHCH=CH] had good neuroprotective activity against PC 12 cell lines showing increased expression of autophagy regulatory proteins (ATG7, LC 3B, p62, Beclin-1) and anti-apoptotic proteins (Bcl-2) and also decreased expression of pro-apoptotic proteins (Bax and Bad). This study demonstrated clearly that compound I [R1 = 4-NH2; R2R3 = HC=CHCH=CH] showed neuroprotective effect through the induction of autophagy and opens up new avenues for a new class of compounds as neuroprotective therapeutic agents. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).Formula: C7H6ClNO2

The Article related to amino dihydrooxazolyl aryl benzenesulfonamide preparation neuroprotective agent autophagy human, aminophenyl sulfonylamino hydroxyethyl aryl carboxamide preparation mitsunobu reaction, hydroxyethyl nitrophenyl sulfonylamino aryl carboxamide preparation reduction catalyst iron, nitrophenyl sulfonylamino aryl carboxylic acid preparation aminoethanol coupling and other aspects.Formula: C7H6ClNO2

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On September 16, 2016, Zhang, Ziqian; Li, Yi; He, Haihong; Qian, Xuhong; Yang, Youjun published an article.SDS of cas: 99-60-5 The title of the article was Mild Chemotriggered Generation of a Fluorophore-Tethered Diazoalkane Species via Smiles Rearrangement. And the article contained the following:

Nitrosamino naphthalenedicarboximide I and a related disulfide underwent Smiles rearrangement in the presence of nucleophiles to generate diazo compounds in situ under mild conditions (in aqueous buffer or MeCN at ambient temperature); reaction with nucleophiles such as carboxylic acids RCO2H [R = Me, i-Pr, Me(CH2)10, (E,E)-MeCH:CHCH:CH, Me2C:CH, 1-adamantyl, Ph, 3-HOC6H4, 2-HOC6H4, 2-Ph2PC6H4, 4-MeC6H4, 4-BrC6H4, 4-O2NC6H4, 2-Cl-4-O2NC6H3, 4-Et2NC6H4, 1-naphthyl] or dimethylamine or activation with glutathione yielded fluorescent products such as acyloxyethylthio naphthalenedicarboximides II [R = Me, i-Pr, Me(CH2)10, (E,E)-MeCH:CHCH:CH, Me2C:CH, 1-adamantyl, Ph, 3-HOC6H4, 2-HOC6H4, 2-Ph2PC6H4, 4-MeC6H4, 4-BrC6H4, 4-O2NC6H4, 2-Cl-4-O2NC6H3, 4-Et2NC6H4, 1-naphthyl] in 16-45% yields. The structure of I was determined by X-ray crystallog. The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).SDS of cas: 99-60-5

The Article related to nitrosamino naphthalenedicarboximide preparation rearrangement nucleophile, acyloxyethylthio naphthalenedicarboximide preparation fluorescence, diazo compound formation smiles rearrangement nitrosamino naphthalenedicarboximide, carboxylic acid reaction in situ generated diazo compound, acetylthioethyl nitrosamino naphthalenedicarboximide mol crystal structure and other aspects.SDS of cas: 99-60-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

On June 30, 2022, Watanabe, Akio; Hirooka, Yasuo; Tsuboi, Kazuma published a patent.SDS of cas: 59833-69-1 The title of the patent was Preparation of N-phenyl-1H-pyrazolecarboxamides, N-phenyl-1H-pyrrolecarboxamides, and N-phenylbenzamides as prostanoid receptor EP2 antagonists. And the patent contained the following:

The title anilides represented by formula I [R1 = CO2 R101, SO3H, SO2NHR102, CONHSO2R103, SO2NHCOR104, CONR105R106, tetrazolyl, or cyano; R101-R106 = each independently H, C1-4 alkyl, C1-4 alkoxy, C1-4 halo alkyl, or dimethylamino; R8, R9 = each independently H, halo, C1-4 alkyl, or HO; when R8 = R9 = C1-4 alkyl, R8 and R9 are bonded to the adjacent benzene ring at o-position to form a C3-7 carbocyclic ring; R2 = H or C1-4 alkyl; R3 = halo, HO, cyano, or each (un)substituted C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, 3-6 membered ring group,NH2, or SH, etc.; R4 = halo or each (un)substituted C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, 3-6 membered ring group, O-(3-6 membered ring group), C1-4 alkylene-(3-5 membered ring group); R5 = CF3 or each (un)substituted C3-10 carbocyclyl or 3-10 membered heterocyclyl; Y = a bond, O, or optionally oxidized S; L = each (un)substituted C1-8 alkylene, C2-8 alkenylene, or C2-8 alkynylene each optionally having the CH2 group replaced with O, S, S(O), or SO2; ring 1 = nitrogen-containing mono- or bicyclic ring; n = 1, 2, 3, or 4; m = 0, 1, 2, or 3] or pharmaceutically acceptable salts thereof are prepared The compounds I have an antagonistic activity against EP2 receptor, good solubility, and high stability against human liver microsome and provide medicines for the prevention and/or treatment of a disease caused by activation of an EP2 receptor. The disease includes endometriosis, uterine myoma, menorrhagia, adenomyosis, dysmenorrhea, chronic pelvic pain syndrome, cancer, inflammatory pain, neuropathic pain, headache, migraine, postoperative pain, interstitial cystitis, leiomyoma, irritable colon syndrome, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, rheumatism, osteoarthritis, gout, allergic disease, hypertension, brain damage, ischemia , Stroke, renal disease, transplant rejection, atherosclerosis, ischemic heart disease, acne vulgaris, asthma, prostatitis, glomerulonephritis, sarcoidosis, vasculitis, or autoimmune disease. More specifically the cancer is breast cancer, ovarian cancer, colon cancer, lung cancer, prostate cancer, head and neck cancer, lymphoma, uveal melanoma, thymoma, mesoderma, esophageal cancer, gastric cancer, duodenal cancer, hepatocellular carcinoma, bile duct cancer, gallbladder cancer cancer, pancreatic cancer, renal cell carcinoma , renal and urinary tract cancer, bladder cancer, penis cancer, testis cancer, uterine cancer, vaginal cancer, genital cancer, skin cancer (For example, malignant melanoma), malignant bone tumor, Soft tissue sarcoma, chondrosarcoma, leukemia, myelodysplastic syndrome, brain tumor or multiple myeloma. Thus, etherification of Me 2-[3-[[[1-(sec-butyl)-5-[2-[(2-fluoropyridin-4-yl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetate with 2-fluoro-4-hydroxypyridine using cyanomethylenetributylphosphorane in toluene at 90° for 2.5 h gave Me 2-[3-[[[1-(sec-butyl)-5-[2-[(2-fluoropyridin-4-yl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetate which underwent alkali hydrolysis in a mixture of 5 N aqueous NaOH solution and methanol at room temperature for 30 min followed by acidification with 2 N aqueous HCl solution to give [3-[[[1-sec-Butyl-5-[2-[(2-fluoro-4-pyridinyl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetic acid (II). II and [3-[[[1-((2S)-2-butyl)-5-[2-[(2-chloro-6-fluoro-4-pyridinyl)oxy]ethyl]-1H-pyrrol-2-yl]carbonyl]amino]-4-(trifluoromethyl)phenyl]acetic acid (III) inhibited the PGE2-induced production of cAMP in CHO cells expressing human EP2 receptor with IC50 of 2.5 and 0.3 nM, resp., and exhibited a selective EP2 selectivity over production DP receptor with a DP/EP2 receptor inhibition selectivity ratio of 2,565 and 3,681, resp. A tablet formulation containing II was described. The experimental process involved the reaction of Methyl 2-(3-amino-4-chlorophenyl)acetate(cas: 59833-69-1).SDS of cas: 59833-69-1

The Article related to anilide preparation prostanoid receptor ep2 selective antagonist, anticancer phenylpyrazolecarboxamide phenylpyrrolecarboxamide phenylbenzamide preparation, cancer endometriosis uterine myoma menorrhagia adenomyosis dysmenorrhea treatment, phenylpyrazolecarboxamide phenylpyrrolecarboxamide phenylbenzamide preparation prostanoid receptor ep2 selective antagonist and other aspects.SDS of cas: 59833-69-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics